发明名称 |
Hyaluronate compositions |
摘要 |
The present invention provides compositions suitable for topical administration to a mammalian subject including sodium hyaluronate and a pharmaceutically acceptable excipient. The present invention also provides methods for making and using the same. |
申请公布号 |
US9107882(B2) |
申请公布日期 |
2015.08.18 |
申请号 |
US201313915818 |
申请日期 |
2013.06.12 |
申请人 |
PERNIX THERAPEUTICS HOLDINGS, INC. |
发明人 |
Lewis Robert |
分类号 |
C08B37/00;A61K31/00;A61K31/164;A61K8/73;A61K9/00;A61K31/728;A61K45/06;A61K31/327;A61K31/4174;A61K31/522;A61K31/7056;A61Q19/00 |
主分类号 |
C08B37/00 |
代理机构 |
Foley & Lardner, LLP |
代理人 |
Foley & Lardner, LLP |
主权项 |
1. A composition suitable for topical administration to a mammalian subject, the composition comprising, by mass, from about 0.05% to about 5% sodium hyaluronate and a pharmaceutically acceptable excipient, wherein from about 0.001 wt % to about 5 wt % of the sodium hyaluronate in the composition has a molecular weight ranging between about 0.01 megadaltons and about 0.4 megadaltons; at least 50 wt % of the sodium hyaluronate in the composition has a molecular weight ranging between about 1.65 and 4.0 megadaltons and less than about 0.001 wt % of the sodium hyaluronate in the composition has a molecular weight above about 4.0 megadaltons;
and wherein the pharmaceutically acceptable excipient is predominantly in the liquid phase at ambient temperature. |
地址 |
Morristown NJ US |